HCPCS E0601: Continuous Positive Airway Pressure (CPAP) Device
Commercial payers pay $297 on average nationally for this procedure.
HCPCS Level II code E0601 represents a continuous positive airway pressure (CPAP) device used to provide positive airway pressure therapy for patients with obstructive sleep apnea; the service type is durable medical equipment and the typical site of service is home use for ongoing respiratory support.
For related coverage guidance, see recent payer policy updates: Interferential Stimulation Devices (for home use), Prior Authorization for Durable Medical Equipment (DME), Breast Pumps.
Customize your policy alerts
Sign up for hcpcs E0601 policy alerts
Get alerted when payer policies referencing E0601 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for HCPCS E0601 centers on BUCA’s average commercial rate of $296.70 as a mid-market benchmark, with individual payers showing meaningful differences in central tendency and upper-tail variation. Blue Cross Blue Shield posts the highest observed maximum at $1,452.70 and a mean of $295.70, while Aetna’s mean sits lower at $238.00 and Cigna’s at $290.50; UnitedHealth Group carries a higher mean of $365.70 and a median of $358.50, indicating more payments clustered at the upper end compared with other payers.
Rate dispersion measured by the interquartile spread (P75 minus P25) highlights relative tightness and volatility: Aetna’s IQR is $350.00 (P75 $395.00 minus P25 $45.00), Blue Cross Blue Shield’s IQR is $437.10 (P75 $510.00 minus P25 $62.90), Cigna’s IQR is $279.10 (P75 $335.80 minus P25 $58.90), UnitedHealth Group’s IQR is $412.80 (P75 $475.10 minus P25 $206.30), and BUCA’s IQR is $385.30 (P75 $463.70 minus P25 $80.40). Cigna shows the tightest interquartile dispersion while Blue Cross Blue Shield shows the widest.